Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial

BACKGROUND: To provide evidence that the Chinese herbal medicine (CHM) PSORI-CM01 combined with Western medicine reduces the relapse rate of psoriasis vulgaris (PV), we plan to conduct a large-scale randomized control trial (RCT). In order to improve and perfect the RCT, this pilot study was designe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Dan-Ni, Lu, Chuan-Jian, Wen, Ze-Huai, Yan, Yu-Hong, Xuan, Mei-Ling, Li, Xiao-Yan, Li, Geng, He, Ze-Hui, Xie, Xiu-Li, Deng, Jing-Wen, Guo, Xin-Feng, Ou, Ai-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793560/
https://www.ncbi.nlm.nih.gov/pubmed/26983642
http://dx.doi.org/10.1186/s13063-016-1272-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793560/
https://www.ncbi.nlm.nih.gov/pubmed/26983642
http://dx.doi.org/10.1186/s13063-016-1272-x

Ejemplares similares